Novo Nordisk Battles Risks from Compounded Drug Copies: Urgent Call for Regulatory Action ...Middle East

Devdiscourse - Opinion
Novo Nordisk Battles Risks from Compounded Drug Copies: Urgent Call for Regulatory Action
Novo Nordisk has voiced serious concerns about the safety of compounded copycat drugs mimicking its weight-loss and diabetes treatments, Wegovy and Ozempic. These unauthorized versions are linked to 10 deaths and 100 hospitalizations, raising alarm within the company.

Hence then, the article about novo nordisk battles risks from compounded drug copies urgent call for regulatory action was published today ( ) and is available on Devdiscourse ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Novo Nordisk Battles Risks from Compounded Drug Copies: Urgent Call for Regulatory Action )

Apple Storegoogle play

Last updated :

Also on site :